# EDGAR Filing Document

**Accession Number:** 0001828673
**File Stem:** 0001193125-26-047207
**Filing Date:** 2026-2
**Character Count:** 2378
**Document Hash:** 07ff709fe82e10b75d67e00bbf75135a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-047207.hdr.sgml**: 20260429

**ACCESSION NUMBER**: 0001193125-26-047207

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260211

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HCW Biologics Inc.
- **CENTRAL INDEX KEY:** 0001828673
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 825024477
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 2929 N COMMERCE PKWY
- **CITY:** MIRAMAR
- **STATE:** FL
- **ZIP:** 33025
- **BUSINESS PHONE:** 954-842-2024

**MAIL ADDRESS:**
- **STREET 1:** 2929 N COMMERCE PKWY
- **CITY:** MIRAMAR
- **STATE:** FL
- **ZIP:** 33025

![LOGO](g55258g0212045012810.jpg)

February 11, 2026

**<u>VIA EDGAR AND E-MAIL</u>**

Mr. James McNamara

Office of Life Sciences

Division of Corporate Finance

U.S. Securities and Exchange Commission

100 F. Street, N.E.

Washington, DC 20549-7010

---

| | |
|:---|:---|
| **Re:** | **HCW Biologics Inc. Registration Statement on Form S-1; <br>Commission File No. 333-293396**  |

---

Dear Mr. McNamara:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, HCW Biologics Inc. (the "Company") hereby requests that the effectiveness of the Company's Registration Statement on Form S-1 (File No. 333-293396), filed on February 11, 2026, be accelerated by the U.S. Securities and Exchange Commission to 5:00 p.m. Eastern Time on Friday, February 13, 2026, or as soon thereafter as is practicable.

The Company hereby authorizes James Groth or Jeny Zarmon of Clark Hill PLC to orally modify or withdraw this request for acceleration. Please contact Mr. Groth at (312) 701-6830 or Ms. Zarmon at (609) 785-2918 with any questions you may have concerning this request, and please notify them when this request for acceleration has been granted.

Thank you for your courtesy and cooperation in this matter.

Very truly yours,

---

| | |
|:---|:---|
| HCW BIOLOGICS INC. | HCW BIOLOGICS INC. |
| By: | */s/ Hing Wong* |
|  | Hing Wong, Founder and CEO |

---

HCW Biologics acceleration request for S-1 February 2026

2929 N Commerce Parkway \| Miramar, Florida 33025, USA \| Phone 954-842-2024 \| Fax 954-842-2037 \|